What is Alnylam Pharmaceuticals's PP&E (net)?

Alnylam Pharmaceuticals (ALNY) reported PP&E (net) of $554.14M in Q2 2026.

How has Alnylam Pharmaceuticals's PP&E (net) changed year-over-year?

Alnylam Pharmaceuticals's PP&E (net) increased by 10.9% year-over-year, from $499.79M to $554.14M.

What is the long-term trend for Alnylam Pharmaceuticals's PP&E (net)?

Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's PP&E (net) has grown at a 2.0% compound annual growth rate (CAGR), from $465.03M to $513.15M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Alnylam Pharmaceuticals ALNY PP&E (Net)

PP&E (Net) at other companies

Ionis PharmaceuticalsIONS

$155.13M+38.6%

Arrowhead ResearchARWR

$374.82M-2.6%

PTC TherapeuticsPTCT

$52.74M-11.3%

Assembly BiosciencesASMB

$214K-14.7%

Arbutus Biopharma CorporationABUS

$22K-86.9%

Wave Life SciencesWVE

$6.83M-24.4%

Other financials

Income statement

See full

Revenue$1.3B+66.9%

Gross profit$992.7M+57.2%

Operating income$231.4M+1,529%

Net income$164.5M+348%

EPS (diluted)$1.21+337%

Balance sheet

See full

Cash & equivalents$1.7B+53.2%

Total debt$256.4M-5.2%

Total equity$1.4B+440%

Total assets$5.6B+21.7%

Cash flow

See full

Operating cash flow$326.7M+113%

CapEx$34.7M+143%

Free cash flow$292.0M+109%

Valuation

See full

Market cap$38.27B-13.6%

Enterprise value$36.81B-15.3%

P/E52.2×—

P/S8×-10.0×

Profitability

See full

Gross margin79.8%-4.1pp

Operating margin20.8%+16.5pp

Net margin15.3%+10.7pp

FCF margin16.5%+14.8pp

Returns & leverage

See full

Return on equity91.4%—

Debt / equity0.2×-0.9×

Current ratio3.1×+0.3×

Where this comes from

Reported directly by Alnylam Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alnylam Pharmaceuticals's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alnylam Pharmaceuticals's PP&E (net)?: Alnylam Pharmaceuticals (ALNY) reported PP&E (net) of $554.14M in Q2 2026.
How has Alnylam Pharmaceuticals's PP&E (net) changed year-over-year?: Alnylam Pharmaceuticals's PP&E (net) increased by 10.9% year-over-year, from $499.79M to $554.14M.
What is the long-term trend for Alnylam Pharmaceuticals's PP&E (net)?: Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's PP&E (net) has grown at a 2.0% compound annual growth rate (CAGR), from $465.03M to $513.15M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.